Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Year: 2017
Type: review
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, FLT3 inhibitors, IDH1/2 inhibitors, venetoclax, CPX-351, midostaurin, glasdegib, pracinostat, targeted therapy, actionable mutations, high-dose cytarabine, hypomethylating agents, elderly patients, clinical trials
Open Access status: closed
Award: Cancer Center Support Grant
OpenAlex ID: W2593230508
